NCI Awards $2.3M Grant to Advance Possible Therapy for Triple-negative Breast Cancer
News
The National Cancer Institute has awarded a Fast Track Small Business Innovation Research grant to Agilvax to support development of the company’s lead immunotherapy candidate, AX09, for an aggressive and difficult-to-treat breast ... Read more